Resveratrol inhibited cell cycle progression by enhancing the levels of cyclin E and cyclin A21, 22 and by decreasing cyclin D19, 21 which suggests that resveratrol, at doses ≤50 μM, exerts mainly cytostatic but not cytotoxic effects on colon cancer cells. The gene discussed is CCNE1; the disease is malignant colon neoplasm.